Quantitative evaluation of the use of actigraphy for neurological and psychiatric disorders

Weidong Pan, Yu Song, Shin Kwak, Sohei Yoshida, Yoshiharu Yamamoto, Weidong Pan, Yu Song, Shin Kwak, Sohei Yoshida, Yoshiharu Yamamoto

Abstract

Quantitative and objective evaluation of disease severity and/or drug effect is necessary in clinical practice. Wearable accelerometers such as an actigraph enable long-term recording of a patient's movement during activities and they can be used for quantitative assessment of symptoms due to various diseases. We reviewed some applications of actigraphy with analytical methods that are sufficiently sensitive and reliable to determine the severity of diseases and disorders such as motor and nonmotor disorders like Parkinson's disease, sleep disorders, depression, behavioral and psychological symptoms of dementia (BPSD) for vascular dementia (VD), seasonal affective disorder (SAD), and stroke, as well as the effects of drugs used to treat them. We believe it is possible to develop analytical methods to assess more neurological or psychopathic disorders using actigraphy records.

References

    1. Pan W, Ohashi K, Yamamoto Y, Kwak S. Power-law temporal autocorrelation of activity reflects severity of parkinsonism. Movement Disorders. 2007;22(9):1308–1313.
    1. Li X, Liu J, Li S, Wang YC, Zhou P. Examination of hand muscle activation and motor unit indices derived from surface EMG in chronic stroke. IEEE Transactions on Biomedical Engineering. 2014;(99):p. 1.
    1. Abbate S, Avvenuti M, Light J. Usability study of a wireless monitoring system among Alzheimer's disease elderly population. International Journal of Telemedicine and Applications. 2014;2014:8 pages.617495
    1. Alonge F, Cucco E, D'Ippolito F, Pulizzotto A. The use of accelerometers and gyroscopes to estimate hip and knee angles on gait analysis. Sensors. 2014;14(5):8430–8446.
    1. Gupta P, Dallas T. Feature selection and activity recognition system using a single triaxial accelerometer. IEEE Transactions on Biomedical Engineering. 2014;61(6):1780–1786.
    1. van Someren EJW, Pticek MD, Speelman JD, Schuurman PR, Esselink R, Swaab DF. New actigraph for long-term tremor recording. Movement Disorders. 2006;21(8):1136–1143.
    1. Pan W, Kwak S, Li F, et al. Actigraphy monitoring of symptoms in patients with Parkinson's disease. Physiology and Behavior. 2013;119:156–160.
    1. Sun Y, Wu C, Wang J, Pan W. Quantitative evaluation of movement disorders by specified analysis according to actigraphy records. International Journal of Integrative Medicine. 2013;1, article 8
    1. Jean-Louis G, Mendlowicz MV, Gillin JC, et al. Sleep estimation from wrist activity in patients with major depression. Physiology & Behavior. 2000;70(1-2):49–53.
    1. Lockley SW, Skene DJ, Arendt J. Comparison between subjective and actigraphic measurement of sleep and sleep rhythms. Journal of Sleep Research. 1999;8(3):175–183.
    1. Chin K, Oga T, Takahashi K, et al. Associations between obstructive sleep apnea, metabolic syndrome, and sleep duration, as measured with an actigraph, in an urban male working population in Japan. Sleep. 2010;33(1):89–95.
    1. Pan W, Soma R, Kwak S, Yamamoto Y. Improvement of motor functions by noisy vestibular stimulation in central neurodegenerative disorders. Journal of Neurology. 2008;255(11):1657–1661.
    1. Pan W, Yoshida S, Liu Q, et al. Quantitative evaluation of severity of behavioral and psychological symptoms of dementia in patients with vascular dementia. Translational Neurodegeneration. 2013;2, article 9
    1. Katayama S. Actigraph analysis of diurnal motor fluctuations during dopamine agonist therapy. European Neurology. 2001;46(1):11–17.
    1. Matsumoto JY, Dodick DW, Stevens LN, Newman RC, Caskey PE, Fjerstad W. Three-dimensional measurement of essential tremor. Movement Disorders. 1999;14(2):288–294.
    1. Pan W, Liu Y, Fang Z, et al. A compound belonging to traditional Chinese medicine improves nocturnal activity in Parkinson's disease. Sleep Medicine. 2011;12(3):307–308.
    1. Pan W, Kwak S, Li G, et al. Therapeutic effect of Yang-Xue-Qing-Nao granules on sleep dysfunction in Parkinson’s disease. Chinese Medicine. 2013;8(14)
    1. Vinzio S, Ruellan A, Perrin A, Schlienger J, Goichot B. Actigraphic assessment of the circadian rest-activity rhythm in elderly patients hospitalized in an acute care unit. Psychiatry and Clinical Neurosciences. 2003;57(1):53–58.
    1. Goldberger AL, Amaral LA, Glass L, et al. PhysioBank, PhysioToolkit, and PhysioNet: components of a new research resource for complex physiologic signals. Circulation. 2000;101(23):E215–E220.
    1. Peng C-K, Havlin S, Stanley HE, Goldberger AL. Quantification of scaling exponents and crossover phenomena in nonstationary heartbeat time series. Chaos. 1995;5(1):82–87.
    1. Yamamoto Y, Struzik ZR, Soma R, Ohashi K, Kwak S. Noisy vestibular stimulation improves autonomic and motor responsiveness in central neurodegenerative disorders. Annals of Neurology. 2005;58(2):175–181.
    1. Struzik ZR, Hayano J, Soma R, Kwak S, Yamamoto Y. Aging of complex heart rate dynamics. IEEE Transactions on Biomedical Engineering. 2006;53(1):89–94.
    1. Kotani K, Struzik ZR, Takamasu K, Stanley HE, Yamamoto Y. Model for complex heart rate dynamics in health and diseases. Physical Review E—Statistical, Nonlinear, and Soft Matter Physics. 2005;72(4)041904
    1. Ohashi K, Amaral LAN, Natelson BH, Yamamoto Y. Asymmetrical singularities in real-world signals. Physical Review E: Statistical, Nonlinear, and Soft Matter Physics. 2003;68(6):652041–652044.065204
    1. Ohashi K, Polcari A, Teicher MH. Scale-invariant locomotor activity patterns in children with SAD. International Journal of Integrative Medicine. 2013;1, article 12
    1. Martinez-Martin P, Rodriguez-Blazquez C, Abe K, et al. International study on the psychometric attributes of the non-motor symptoms Scale in Parkinson disease. Neurology. 2009;73(19):1584–1591.
    1. Martinez-Martin P, Gil-Nagel A, Gracia LM, et al. Unified Parkinson’s disease rating scale characteristics and structure. The cooperative multicentric group. Movement Disorders. 1994;9:76–83.
    1. Comella CL, Morrissey M, Janko K. Nocturnal activity with nighttime pergolide in Parkinson disease: a controlled study using actigraphy. Neurology. 2005;64(8):1450–1451.
    1. Pan W, Kwak S, Liu Y, et al. Traditional chinese medicine improves activities of daily living in parkinson's disease. Parkinson's Disease. 2011;2011:7 pages.789506
    1. Pan W, Zhou H. Inclusion of integrative medicine in clinical practice. Integrative Medicine International. 2014;1:1–4.
    1. Qi C, Song X, Wang J, Qin B, Pan W, Su X. Bufei Huoxue capsules improve sleep disorders in geriatric chronic obstructive pulmonary disease. Shang Hai Zhong Yi Yao Da Xue Xue Bao. 2013;47(8):35–38.
    1. Jiang L, Wu X. Research on the relationship between sleep phases and heart rate variability. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2011;28(1):148–152.
    1. Lee JM, Kim DJ, Kim IY, Park K, Kim SI. Detrended fluctuation analysis of EEG in sleep apnea using MIT/BIH polysomnography data. Computers in Biology and Medicine. 2002;32(1):37–47.
    1. Bakken LN, Kim HS, Finset A, Lerdal A. Stroke patients' functions in personal activities of daily living in relation to sleep and socio-demographic and clinical variables in the acute phase after first-time stroke and at six months of follow-up. Journal of Clinical Nursing. 2012;21(13-14):1886–1895.
    1. Nakamura T, Kiyono K, Yoshiuchi K, Nakahara R, Struzik ZR, Yamamoto Y. Universal scaling law in human behavioral organization. Physical Review Letters. 2007;99(13)138103
    1. Mahlberg R, Walther S. Actigraphy in agitated patients with dementia: monitoring treatment outcomes. Zeitschrift fur Gerontologie und Geriatrie. 2007;40(3):178–184.
    1. Mahlberg R, Walther S, Eichmann U, Tracik F, Kunz D. Effects of rivastigmine on actigraphically monitored motor activity in severe agitation related to Alzheimer's disease: a placebo-controlled pilot study. Archives of Gerontology and Geriatrics. 2007;45(1):19–26.
    1. Hu K, Van Someren EJW, Shea SA, Scheer FAJL. Reduction of scale invariance of activity fluctuations with aging and Alzheimer's disease: involvement of the circadian pacemaker. Proceedings of the National Academy of Sciences of the United States of America. 2009;106(8):2490–2494.
    1. Kim J, Nakamura T, Kikuchi H, Sasaki T, Yamamoto Y. Co-variation of depressive mood and locomotor dynamics evaluated by ecological momentary assessment in healthy humans. PLoS ONE. 2013;8(9)e74979

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi